Recent News

• 04.24.2025 - Treace to Report First Quarter 2025 Financial Results on May 8, 2025
• 04.24.2025 - Treace to Report First Quarter 2025 Financial Results on May 8, 2025
• 04.07.2025 - Treace Announces Upcoming Board Chair Transition
• 04.07.2025 - Treace Announces Upcoming Board Chair Transition
• 03.28.2025 - Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
• 03.28.2025 - Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
• 03.25.2025 - Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference
• 03.25.2025 - Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference

Recent Filings

• 04.07.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.07.2025 - EX-99.1 EX-99.1
• 04.07.2025 - 8-K Current report
• 04.07.2025 - DEF 14A Other definitive proxy statements
• 04.07.2025 - ARS Annual Report to Security Holders
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2025 - 144 Report of proposed sale of securities
• 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2025 - 4 Statement of changes in beneficial ownership of securities